Adam Spatacco is an FP&A Specialist who writes for financial publications such as The Motley Fool and Yahoo Finance. His articles focus on providing investment insights and analysis, particularly in the areas of artificial intelligence stocks, dividend stocks, and market trends. Adam's work has also been featured in Nasdaq and Yahoo Finance Singapore.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Adam Spatacco's coverage mainly focuses on investment analysis with a specific emphasis on stock market trends, AI, and dividend stocks. His articles often refer to data in support of the investment analysis.
Given his focus on investment analysis, he is likely to be interested in pitches from financial experts who can provide unique insights into stock market trends, AI-related companies, and dividend stocks. These could include professionals with a track record of successful predictions or those with insider knowledge of the companies being discussed.
Additionally, given his focus on data-driven content and themes such as Data & Analytics and Software & SaaS, he may also be open to pitches from experts in quantitative finance or analytics who can provide valuable data-backed perspectives.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Adam Spatacco
Key Points Throughout late October and into early November, Cathie Wood sold over 800,000 shares of Tesla. At the same time, the high-tech investor has made some large-scale buys in Archer Aviation. There are a lot of important details investors need to know about each move and what it could mean. Motley Fool Issues Rare “All In” Buy Alert
Key Points Nvidia stock has gained nearly 1,000% since November 2022, and shares tend to soar particularly around earnings reports. Nvidia's report next week will be about one thing: the upcoming Blackwell launch. While I think the stock will rocket higher following the report, there are some considerations investors need to take into account. Motley Fool Issues Rare “All In” Buy Alert
Key Points The U.S. military has been investing large sums into artificial intelligence (AI) capabilities, and Palantir has remained a consistent staple in the discussion. A recent announcement suggests that the Department of the Navy is gearing up to award Palantir with a contract worth nearly $1 billion. While defense tech is a massive opportunity in the broader AI realm, investors need to consider the full picture before buying Palantir stock right now. Motley Fool Issues Rare “All In” Buy Alert
By: Adam Spatacco
Key Points Cathie Wood has sold about 1.9 million shares of Palantir in the last two months. During the period Wood trimmed her position, the stock rose almost 90%. Palantir's valuation looks stretched right now, and taking profits off the table is perfectly reasonable. Buy Alert: Our 10 best stocks to buy right now (see the list)
Key Points Novo Nordisk continues to witness strong growth across its portfolio of diabetes and obesity care medications. The company's tailwinds include expanded indications and new geographic markets. Its valuation appears to be rightsizing after a prolonged period of gains.
By: Adam Spatacco
Key Points The market for generative AI is expected to continue growing for years, and Nvidia may be best positioned. Even so, the semiconductor landscape has many other budding players -- some of them becoming forgotten. Qualcomm is executing on its turnaround plan, and the stock is a better bargain than Nvidia right now. Buy Alert: Our 10 best stocks to buy right now (see the list)
By: Adam Spatacco
Key Points Ken Griffin's hedge fund, Citadel Advisors, scooped up 1.2 million shares of Tesla stock during the third quarter. The outlook for the company has turned incredibly bullish since Donald Trump was named President-Elect. While Tesla stock looks like a tempting buy right now, there are many important factors to consider before following Griffin's lead. Motley Fool Issues Rare “All In” Buy Alert
Key Points 2024 has been a milestone year for Rocket Lab, and the company's future looks bright. While Rocket Lab's progress is impressive, recent trends in the stock price may suggest that investors are a bit too optimistic. Buy Alert: Our 10 best stocks to buy right now (see the list)
Key Points The pharmaceutical giant's third-quarter earnings missed the mark across the board. Announcements from Amazon and out of Washington, D.C. may also be playing a role. Lilly remains well-positioned to dominate the healthcare space in the long run. Motley Fool Issues Rare “All In” Buy Alert
By: Adam Spatacco
Key Points It's been a rough ride in recent years for chipmaker Intel, but it has at least one new fan. Last quarter, Citadel Advisors sharply increased its position in the beaten-down chip stock. While the outlook for this tech stalwart looks brighter, it still faces a lot of execution risk. 10 stocks we like better than Intel
(833) 317-6278 
